| |
Preschools see sharp drop in funding: study Monday, Apr 29, 2013 11:28 AM PDT By Susan Heavey WASHINGTON (Reuters) - Enrollment in U.S. preschools stalled over the past year as states recovering from the recent recession struggle to fund early education for the nation's youngest students, researchers said. In a report released on Monday, education experts pointed to a record drop of more than half a billion dollars in state funding in the 2011-2012 school year from the prior year. The report also found that for the first time in a decade, the percentage of 3- and 4-year-olds enrolled did not grow. Overall, 1.3 million children attended state-run preschools in 2011-2012. ... Full Story | Top |
South Africa's Mandela frail in first TV footage in months Monday, Apr 29, 2013 11:23 AM PDT JOHANNESBURG (Reuters) - Anti-apartheid hero Nelson Mandela made his first television appearance in almost a year on Monday, looking thin and frail in his Johannesburg home where he has been resting after a bout of pneumonia. The veteran leader stared mostly straight ahead, his face showing little expression in the footage of a visit from President Jacob Zuma and other officials, shown by state broadcaster SABC. ... Full Story | Top |
Merck, Pfizer to jointly develop diabetes drug Monday, Apr 29, 2013 11:20 AM PDT By Ransdell Pierson (Reuters) - Pfizer Inc and Merck & Co Inc said they will co-develop Pfizer's experimental type 2 diabetes drug ertugliflozin, both as a standalone product and in combination with other drugs, including Merck's blockbuster Januvia. The Pfizer medicine belongs to a new class of diabetes treatments called SGLT2 inhibitors. Now nearing Phase III late-stage trials, it is behind similar drugs in development -- including Johnson & Johnson's Invokana (canagliflozin) which was approved by U.S. regulators in late March. ... Full Story | Top |
Five convicted in Kosovo organ trafficking case Monday, Apr 29, 2013 10:38 AM PDT By Fatos Bytyci PRISTINA (Reuters) - Five men were convicted in Kosovo on Monday of involvement in an organ trafficking ring that performed at least 23 illegal kidney transplants at a clinic on the outskirts of the capital, under the noses of United Nations police and NATO peacekeepers. The trial of the men, all citizens of Kosovo, has taken on added significance in the region because it echoes a high-profile probe into alleged organ harvesting by guerrilla fighters during the 1998-99 war. ... Full Story | Top |
Mother forced daughter, 14, into sperm insemination - UK court Monday, Apr 29, 2013 09:27 AM PDT By Estelle Shirbon LONDON (Reuters) - A mother who persuaded her adopted teenage daughter to become pregnant by artificial insemination because she wanted a baby for herself has been jailed for five years in Britain, in a case that raises concern over how easily donor sperm can be obtained. Previously secret court documents showed that the daughter, a virgin, was made to inseminate herself alone in her bedroom seven times over a two-year period starting in 2008 when she was 14, using syringes of semen bought online by the mother from sperm bank Cryos in Denmark. ... Full Story | Top |
Auxilium cuts sales view on drugs, expands urology business Monday, Apr 29, 2013 09:21 AM PDT (Reuters) - Auxilium Pharmaceuticals Inc reported a big fall in quarterly sales in the United States for both its drugs, and said it acquired Actient Holdings LLC to bolster its urology business. Shares of Auxilium fell as much as 13.5 percent to $13.87 — their lowest in a year-and-a-half — on the Nasdaq on Monday. Revenue fell 10 percent in the first quarter to $66.2 million, below analysts' average estimate of $81.23 million, according to Thomson Reuters I/B/E/S. Testosterone gel Testim's sales, almost all of which come from the United States, fell 23 percent to $45.5 million. ... Full Story | Top |
Tabata metes out fitness in short, repeated flashes Monday, Apr 29, 2013 07:27 AM PDT By Dorene Internicola NEW YORK (Reuters) - For people who are too bored or busy to spend an hour on a treadmill an exercise regime that was developed for athletes but is being taught in gyms may help to build fitness in less time. The Tabata Protocol is a four-minute regime that measures fitness in seconds - 20 seconds of full-out work followed by 10 seconds of rest, repeated eight times. Although it can boost fitness levels of the healthy and time-pressed, experts say it is not for everybody and should not be done every day. ... Full Story | Top |
China reports latest bird flu death Monday, Apr 29, 2013 06:48 AM PDT BEIJING (Reuters) - A man in Shanghai died from bird flu on Monday, the latest person to die from the H7N9 strain of the virus first discovered in humans in March that has now killed at least 24 people. The 89-year-old died after 12 days of medical treatment, state news agency Xinhua said, citing Shanghai health authorities. Cases of the virus, confirmed in well over 100 people, have spread to several new provinces in recent days, including Fujian and Hunan. Last week a man in Taiwan became the first case of the flu outside mainland China. He caught the flu while travelling in China. ... Full Story | Top |
South Africa's Mandela in good health, good spirits: ANC Monday, Apr 29, 2013 06:45 AM PDT JOHANNESBURG (Reuters) - Anti-apartheid hero Nelson Mandela is in good health and good spirits, South Africa's ruling African National Congress said on Monday, in the first update on his condition since he was discharged from hospital in early April. President Jacob Zuma and other party leaders visited the 94-year-old former president at his Johannesburg home. "After receiving a briefing from the medical team, the national officials are satisfied that President Mandela is in good health and is receiving the very best medical care," the ANC said. ... Full Story | Top |
FDA rejects two Gilead HIV drugs as standalone products Monday, Apr 29, 2013 06:35 AM PDT By Toni Clarke WASHINGTON (Reuters) - Gilead Sciences Inc said on Monday that U.S. health rejected two of its HIV drugs as standalone therapies, citing deficiencies in documentation and validation of certain quality testing procedures. Gilead said it is working with U.S. Food and Drug Administration to address the questions raised in the rejection letter in order to prove the application forward. The company is seeking approval for its drug elvitegravir for people with HIV, the virus that causes AIDS, who have already been treated with other products. ... Full Story | Top |
Impax, GSK end Parkinson's disease partnership Monday, Apr 29, 2013 06:07 AM PDT (Reuters) - Impax Laboratories Inc said partner GlaxoSmithKline Plc ended their collaboration on Impax's experimental Parkinson's disease drug due to regulatory and launch delays in the countries in which GSK has rights to market the drug. Impax shares fell 2 percent to $17.32 in premarket trade after closing at $17.62 on Friday on the Nasdaq. Under a deal, GlaxoSmithKline had the right to develop and market the drug, IPX066, outside the United States and Taiwan. Rights to the drug, which is known as Rytary in the United States, will transfer back to Impax at the end of July 2013. ... Full Story | Top |
EU drugs agency recommends suspension of tetrazepam Monday, Apr 29, 2013 04:27 AM PDT LONDON (Reuters) - EU drugs regulators have recommended suspending use of all tetrazepam-containing medicines following reports of serious skin reactions, the European Medicines Agency said on Monday. Tetrazepam belong to a class of drugs known as benzodiazepines and is used in several European Union countries to treat conditions such as back and neck pain and spasticity. (Reporting by Kate Kelland, editing by Ben Hirschler) Full Story | Top |
Bayer to buy birth-control devices maker for $1.1 billion Monday, Apr 29, 2013 03:48 AM PDT By Ludwig Burger FRANKFURT (Reuters) - Germany's Bayer AG has agreed to buy U.S. contraceptive devices maker Conceptus for $1.1 billion, aiming to underpin its position as the world's largest women's healthcare provider, Bayer, whose shares were down 2.3 percent by 0823 GMT, will launch a public tender offer to acquire all Conceptus shares for $31.00 each in cash, in an offer agreed with Conceptus's management, Bayer said on Monday. That is a premium of 19. ... Full Story | Top |
Respect women's choice to have home birth: doctors Sunday, Apr 28, 2013 09:09 PM PDT By Genevra Pittman NEW YORK (Reuters Health) - Although hospitals and birthing centers are the safest places to have a baby, pediatricians said today that women who choose to give birth at home should be supported and that setting made as safe as possible, as well. Planned home birthing, they said, may be an option for healthy moms-to-be who are due to have a single, on-time baby. A certified nurse-midwife, midwife or doctor should be present and a previous agreement made with a nearby hospital in case transfer is needed, according to the American Academy of Pediatrics (AAP) policy statement. ... Full Story | Top |
In abortion debate, both sides point to Philadelphia trial Sunday, Apr 28, 2013 09:04 PM PDT Full Story | Top |
|
No comments:
Post a Comment